UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Lancet neurology, 2013-02, Vol.12 (2), p.207-216

2013

Volltextzugriff (PDF)

The search for clarity regarding "clinically meaningful outcomes" in Alzheimer disease clinical trials: CLARITY-AD and Beyond

Alzheimer's research & therapy, 2024-02, Vol.16 (1), p.37-13, Article 37

2024

Volltextzugriff (PDF)

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

Lancet neurology, 2014-10, Vol.13 (10), p.997-1005

2014

Volltextzugriff (PDF)

Baseline Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Population-Based Study

The American journal of psychiatry, 2014-05, Vol.171 (5), p.572-581

2014

Volltextzugriff (PDF)

BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis

Developmental cell, 2012-07, Vol.23 (1), p.137-152

2012

Volltextzugriff (PDF)

Mild cognitive impairment due to Alzheimer disease in the community

Annals of neurology, 2013-08, Vol.74 (2), p.199-208

2013

Volltextzugriff (PDF)

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches

American journal of human genetics, 2018-02, Vol.102 (2), p.233-248

2018

Volltextzugriff (PDF)

A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1), p.265-275

2013

Volltextzugriff (PDF)

GPER deficiency impedes murine myocutaneous revascularization and wound healing

Scientific reports, 2024-08, Vol.14 (1), p.18400-12, Article 18400

2024

Volltextzugriff (PDF)

Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients

Journal of the neurological sciences, 2015-02, Vol.349 (1), p.124-128

2015

Volltextzugriff (PDF)

Colorectal Cancer Survival Trends in the United States From 1992 to 2018 Differ Among Persons From Five Racial and Ethnic Groups According to Stage at Diagnosis: A SEER-Based Study

Cancer control, 2022-10, Vol.29, p.107327482211364-10732748221136440

2022

Volltextzugriff (PDF)

Association between mammographic breast density and histologic features of benign breast disease

Breast cancer research : BCR, 2017-12, Vol.19 (1), p.134-134, Article 134

2017

Volltextzugriff (PDF)

The Otago Exercise Program compared to falls prevention education in Zuni elders: a randomized controlled trial

BMC geriatrics, 2022-08, Vol.22 (1), p.652-652, Article 652

2022

Volltextzugriff (PDF)

Association between Quality of Life and Physical Functioning in a Gardening Intervention for Cancer Survivors

Healthcare (Basel), 2022-07, Vol.10 (8), p.1421

2022

Volltextzugriff (PDF)

Albuminuria, cognition, and MRI biomarkers of cerebrovascular disease in American Indians of the Zuni Pueblo

eNeurologicalSci, 2022-12, Vol.29, p.100438-100438, Article 100438

2022

Volltextzugriff (PDF)

Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging

The journals of gerontology. Series A, Biological sciences and medical sciences, 2013-08, Vol.68 (8), p.929-937

2013

Volltextzugriff (PDF)

Brain β-amyloid load approaches a plateau

Neurology, 2013-03, Vol.80 (10), p.890

2013

Volltextzugriff (PDF)

American Indian chronic Renal insufficiency cohort study (AI-CRIC study)

BMC nephrology, 2020-07, Vol.21 (1), p.291-11, Article 291

2020

Volltextzugriff (PDF)

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

JAMA neurology, 2016-01, Vol.73 (1), p.85

2016

Volltextzugriff (PDF)

Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk

Lung cancer (Amsterdam, Netherlands), 2010-10, Vol.70 (1), p.14-21

2010

Volltextzugriff (PDF)

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Brain (London, England : 1878), 2010-11, Vol.133 (11), p.3336-3348

2010

Volltextzugriff (PDF)

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

Neurology, 2013-11, Vol.81 (20), p.1732

2013

Volltextzugriff (PDF)

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control

Journal of cancer research and clinical oncology, 2023-09, Vol.149 (11), p.8673-8680

2023

Volltextzugriff (PDF)

1214-P: Assessing the Efficacy of Home-Based Kidney Care on Patient Activation Measure (PAM) among Patients with Diabetes

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Association of type 2 diabetes with brain atrophy and cognitive impairment

Neurology, 2014-04, Vol.82 (13), p.1132

2014

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(102)

Sprache

Englisch
(102)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alzheimer's & Dementia
(35)
Cancer Research
(14)
Lancet Neurology
(5)
Neurology
(5)
Cancer Epidemiology, Biomarkers & Prevention
(3)
Annals Of Neurology
(2)
Breast Cancer Research
(2)
Breast Cancer Research : Bcr
(2)
Diabetes
(2)
Lung Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

The search for clarity regarding "clinically meaningful outcomes" in Alzheimer disease clinical trials: CLARITY-AD and Beyond

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study

Baseline Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment: A Population-Based Study

BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis

Mild cognitive impairment due to Alzheimer disease in the community

Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches

A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity

GPER deficiency impedes murine myocutaneous revascularization and wound healing

Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients

Colorectal Cancer Survival Trends in the United States From 1992 to 2018 Differ Among Persons From Five Racial and Ethnic Groups According to Stage at Diagnosis: A SEER-Based Study

Association between mammographic breast density and histologic features of benign breast disease

The Otago Exercise Program compared to falls prevention education in Zuni elders: a randomized controlled trial

Association between Quality of Life and Physical Functioning in a Gardening Intervention for Cancer Survivors

Albuminuria, cognition, and MRI biomarkers of cerebrovascular disease in American Indians of the Zuni Pueblo

Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging

Brain β-amyloid load approaches a plateau

American Indian chronic Renal insufficiency cohort study (AI-CRIC study)

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control

1214-P: Assessing the Efficacy of Home-Based Kidney Care on Patient Activation Measure (PAM) among Patients with Diabetes

Association of type 2 diabetes with brain atrophy and cognitive impairment

Suchergebnisse filtern